Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2026-02-02 @ 10:51 PM
Study NCT ID:
NCT01967095
Status:
COMPLETED
Last Update Posted:
2018-11-13
First Post:
2013-10-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-15
First Submit QC Date:
None
Study First Post Date:
2013-10-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-08
Last Update Post Date:
2018-11-13
Last Update Post Date Type:
ACTUAL